Details of the Drug Reposition

General Information of This Drug (ID: DMX3FN4)

Drug Name
ISIS-APOCIII   DMX3FN4
Drug Type
Antisense drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Inflammation DISJUQ5T 1A00-CA43.1 Phase 1 [1]
Metabolic syndrome x DISU8N7X 5C50-5D2Z Phase 1 [1]
Hyperlipemia DIS28TLT 5C80 Phase 1 [1]
Atherosclerosis DISMN9J3 BD40 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).